Who is sponsoring NCT06785168?

NCT06785168 is sponsored by Kieu Nguyen Dang Phuong.

What drugs are being tested in NCT06785168?

Interventions in NCT06785168: Machine-based Resistance Training.

What condition does NCT06785168 study?

NCT06785168 studies Sarcopenia in Elderly, Chronic Heart Failure.

Is NCT06785168 still recruiting?

NCT06785168 is currently recruiting now. Last updated 17 February 2026.

Last reviewed 2026-02-17 · How we verify

NCT06785168

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Resistance Training on Sarcopenia in Older Heart Failure Patients

Recruiting now NA Last updated 17 February 2026

What this trial tests

NA trial testing Machine-based Resistance Training in Sarcopenia in Elderly in 146 participants. Currently enrolling.

Timeline

24 December 2024

Primary endpoint
31 December 2026

31 December 2027

Quick facts

Lead sponsor	Kieu Nguyen Dang Phuong
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	146
Start date	24 December 2024
Primary completion	31 December 2026
Estimated completion	31 December 2027
Sites	2 locations across Vietnam

Drugs / interventions tested

Machine-based Resistance Training

Conditions studied

Sarcopenia in Elderly — all drugs for Sarcopenia in Elderly →
Chronic Heart Failure — all drugs for Chronic Heart Failure →

Sponsor

Kieu Nguyen Dang Phuong

Who can join

60 and older, any sex, with Sarcopenia in Elderly or Chronic Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of study is to evaluate the effects of an eight-week machine-based resistance training program on managing sarcopenia in older outpatients with chronic heart failure (HF) at Military Hospital 175.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sarcopenia in Elderly

Currently open trials in the same condition.

NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
NCT07322653 — The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population · NA · recruiting
NCT06853275 — The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia · NA · recruiting
NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06785168 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kieu Nguyen Dang Phuong
Last refreshed: 17 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06785168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing